Pharmachemie USA

Pharmachemie is a specialized pharmaceutical company focused on the development and production of generic oncology treatments. Based in Haarlem, Netherlands, it operates as a major manufacturing and R&D hub for Teva Pharmaceutical Industries, following its acquisition in 1998. The company is renowned for its expertise in cytotoxic and cytostatic drugs, producing a significant portion of the world's generic chemotherapy supply. Pharmachemie's facilities are equipped for high-containment production of both oral and injectable formulations. Its products are distributed globally, including in the United States, playing a critical role in providing affordable access to essential cancer therapies.